The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

BIOSUIS ParvoEry suspension for injection for pigs

Bioveta, a.s.VPA22028/003/001

Main Information

Trade NameBIOSUIS ParvoEry suspension for injection for pigs
Active SubstancesPorcine parvovirus inactivated
erysipelothrix rhusiopathiae, inactivated
Dosage FormSuspension for injection
Licence HolderBioveta, a.s.
Licence NumberVPA22028/003/001

Group Information

ATC CodeQI09AL01 porcine parvovirus + erysipelothrix
Therapeutic ClassImmunological - Inactivated Vaccine


License statusAuthorised
Licence Issued03/09/2021
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back